Mitochondrial-DNA-Targeted IrIII-Containing Metallohelices with Tunable Photodynamic Therapy Efficacy in Cancer Cells

The development of DNA-targeted photodynamic therapy (PDT) agents for cancer treatment has drawn substantial attention. Herein, the design and synthesis of dinuclear Ir^III-containing luminescent metallohelices with tunable PDT efficacy that target mitochondrial DNA in cancer cells are reported. The metallohelices are fabricated using dynamic imine-coupling chemistry between aldehyde end-capped fac-Ir(ppy)₃ handles and linear alkanediamine spacers, followed by reduction of the imine linkages. The length and odd–even character of the diamine alkyl linker determined the stereochemistry (helicates vs. mesocates). Compared to the helicates, the mesocates exhibit improved apoptosis-induction upon white-light irradiation. Molecular docking studies indicate that the mesocate with a proper length of diamine spacers shows stronger affinity for the minor groove of DNA. This study highlights the potential of DNA-targeting Ir^III-containing metallohelices as PDT agents.     

meso‐(2‐Pyridyl)‐boron(III)‐subporphyrin: Perimeter Iridium(III) Coordination

Peripherally metalated porphyrinoids are promising functional π‐systems displaying characteristic optical, electronic, and catalytic properties. In this work, 5‐(2‐pyridyl)‐ and 5,10,15‐tri(2‐pyridyl)‐B^III‐subporphyrins were prepared and used to produce cyclometalated subporphyrins by reactions with [Cp*IrCl₂]₂, which proceeded through an efficient C?H activation to give the corresponding mono‐ and tri‐Ir^III complexes, respectively. While the mono‐Ir^III complex was obtained as a diastereomeric mixture, a C₃‐symmetric tri‐Ir^III complex with the three Cp*‐units all at the concave side was predominantly obtained in a high yield of 90 %, which displays weak NIR phosphorescence even at room temperature in degassed CH₂Cl₂, differently from the mono‐Ir^III complexes.     

Triphenylamine and carbazole‐modified iridiumIII 2‐phenylpyridine complexes: Synthesis,anticaner application and targeted research

Four half‐sandwich iridium^III (Ir^III) triphenylamine or carbazole‐modified 2‐phenylpyridine (TPA/Cz‐PhPy) complexes ([(η⁵‐Cp*)Ir(C^N)Cl]) were synthesized and characterized. Compared with cisplatin, these complexes show higher activity to A549, HepG2 and HeLa cells, with the IC₅₀ values changed from 2.5 ± 0.1 μM to 14.8 ± 2.6 μM. Additionally, complexes could effectively prevent the migration of cancer cells. Ir^III TPA/Cz‐PhPy complexes could bind to protein and transport through serum protein, catalyze the oxidation of nicotinamide‐adenine dinucleotid (NADH) and induce the accumulation of reactive oxygen species, and eventually lead to apoptosis, which was also confirmed by flow cytometry. Moreover, prominent targeted fluorescence property confirmed that Ir^III TPA/Cz‐PhPy complexes were involved in non‐energy dependent intracellular uptake mechanism, effectively accumulated in lysosomes and damage the integrity of acidic lysosomes, and eventually induce cell death. Above all, TPA/Cz‐appended half‐sandwich Ir^III phenylpyridine complexes are promising anticancer agents with dual functions, including migration inhibition and lysosomal damage.     

2‐(2′‐Pyridyl)‐4,6‐diphenylphosphinine versus 2‐(2′‐Pyridyl)‐4,6‐diphenylpyridine: Synthesis,Characterization, and Reactivity of Cationic RhIII and IrIII Complexes Based on Aromatic Phosphorus Heterocycles

The bidentate P,N hybrid ligand 1 allows access for the first time to novel cationic phosphinine‐based Rh^III and Ir^III complexes, broadening significantly the scope of low‐coordinate aromatic phosphorus heterocycles for potential applications. The coordination chemistry of 1 towards Rh^III and Ir^III was investigated and compared with the analogous 2,2′‐bipyridine derivative, 2‐(2′‐pyridyl)‐4,6‐diphenylpyridine ( 2 ), which showed significant differences. The molecular structures of [RhCl(Cp*)( 1 )]Cl and [IrCl(Cp*)( 1 )]Cl (Cp*=pentamethylcyclopentadienyl) were determined by means of X‐ray diffraction and confirm the mononuclear nature of the λ³‐phosphinine–Rh^III and Ir^III complexes. In contrast, a different reactivity and coordination behavior was found for the nitrogen analogue 2 , especially towards Rh^III as a bimetallic ion pair [RhCl(Cp*)( 2 )]⁺[RhCl₃(Cp*)]^? is formed rather than a mononuclear coordination compound. [RhCl(Cp*)( 1 )]Cl and [IrCl(Cp*)( 1 )]Cl react with water regio‐ and diastereoselectively at the external P?C double bond, leading exclusively to the anti‐addition products [MCl(Cp*)( 1 H ? OH)]Cl as confirmed by X‐ray crystal‐structure determination.     

Tuning the Excited State of Water‐Soluble IrIII‐Based DNA Intercalators that are Isostructural with [RuII(NN)2(dppz)] Light‐Switch Complexes

The synthesis of two new Ir^III complexes which are effectively isostructural with well‐established [Ru(NN)₂(dppz)]²⁺ systems is reported (dppz=dipyridophenazine; NN=2,2′‐bipyridyl, or 1,10‐phenanthroline). One of these Ir^III complexes is tricationic and has a conventional N₆ coordination sphere. The second dicationic complex has a N₅C coordination sphere, incorporating a cyclometalated analogue of the dppz ligand. Both complexes show good water solubility. Experimental and computational studies show that the photoexcited states of the two complexes are very different from each other and also differ from their Ru^II analogues. Both of the complexes bind to duplex DNA with affinities that are two orders of magnitude higher than previously reported Ir(dppz)‐based systems and are comparable with Ru^II(dppz) analogues.     

Encapsulation and Enhanced Luminescence Properties of IrIII Complexes within a Hexameric Self‐Assembled Capsule

Encapsulation and luminescence studies of [Ir(ppy)₂(bpy)]Cl (ppy=2‐phenylpyridinate, bpy=2,2′‐bipyridine) within a hexameric resorcinarene capsule are reported. One Ir^III complex cation was encapsulated within the capsule, as demonstrated by NMR and dynamic light scattering (DLS) studies. The emission color of the Ir^III complex was drastically changed from orange to yellow by encapsulation, in contrast with the lack of significant changes in the absorption spectrum. The hexameric capsule effectively hampers the non‐radiative pathway to increase both the luminescence quantum yield and the exited state lifetime. The luminescent properties of the encapsulated Ir^III complex depend on the ratio of Ir^III complex to the resorcinarene monomer as well as the concentration of resorcinarene monomer owing to the reversible process of self‐assembly of the hexameric capsule. Quenching experiments revealed that the Ir^III complex in the capsule was effectively separated from quenchers.     

Tuning the Cellular Uptake Properties of Luminescent Heterobimetallic Iridium(III)–Ruthenium(II) DNA Imaging Probes

The synthesis of two new luminescent dinuclear Ir^III–Ru^II complexes containing tetrapyrido[3,2‐a:2′,3′‐c:3′′,2′′‐h:2′′′,3′′′‐j]phenazine (tpphz) as the bridging ligand is reported. Unlike many other complexes incorporating cyclometalated Ir^III moieties, these complexes display good water solubility, allowing the first cell‐based study on Ir^III–Ru^II bioprobes to be carried out. Photophysical studies indicate that emission from each complex is from a Ru^II excited state and both complexes display significant in vitro DNA‐binding affinities. Cellular studies show that each complex is rapidly internalised by HeLa cells, in which they function as luminescent nuclear DNA‐imaging agents for confocal microscopy. Furthermore, the uptake and nuclear targeting properties of the complex incorporating cyclometalating 2‐(4‐fluorophenyl)pyridine ligands around its Ir^III centre is enhanced in comparison to the non‐fluorinated analogue, indicating that fluorination may provide a route to promote cell uptake of transition‐metal bioprobes.     

Formation of Novel Dinuclear Lanthanide Luminescent Samarium(III), Europium(III), and Terbium(III) Triple‐Stranded Helicates from a C2‐Symmetrical Pyridine‐2,6‐dicarboxamide‐Based 1,3‐Xylenediyl‐Linked Ligand in MeCN

The synthesis of the C₂‐symmetrical ligand 1 consisting of two naphthalene units connected to two pyridine‐2,6‐dicarboxamide moieties linked by a xylene spacer and the formation of Ln^III‐based (Ln=Sm, Eu, Tb, and Lu) dimetallic helicates [Ln₂? 1 ₃] in MeCN by means of a metal‐directed synthesis is described. By analyzing the metal‐induced changes in the absorption and the fluorescence of 1 , the formation of the helicates, and the presence of a second species [Ln₂? 1 ₂] was confirmed by nonlinear‐regression analysis. While significant changes were observed in the photophysical properties of 1 , the most dramatic changes were observed in the metal‐centred lanthanide emissions, upon excitation of the naphthalene antennae. From the changes in the lanthanide emission, we were able to demonstrate that these helicates were formed in high yields (ca. 90% after the addition of 0.6 equiv. of Ln^III), with high binding constants, which matched well with that determined from the changes in the absorption spectra. The formation of the Lu^III helicate, [Lu₂? 1 ₃], was also investigated for comparison purposes, as we were unable to obtain accurate binding constants from the changes in the fluorescence emission upon formation of [Sm₂? 1 ₃], [Eu₂? 1 ₃], and [Tb₂? 1 ₃].     

Self‐Assembled Triple‐Stranded Lanthanide Dimetallic Helicates with a Ditopic Ligand Derived from Bis(benzimidazole)pyridine and Featuring an (4‐Isothiocyanatophenyl)ethynyl Substituent

Bis(2‐{6‐(diethylcarbamoyl)‐4‐[(4‐isothiocyanatophenyl)ethynyl]pyridin‐2′‐yl}‐1‐ethylbenzimidazol‐5‐yl)methane ( L ^G ) reacts with trivalent lanthanide ions in acetonitrile to yield triple‐stranded dimetallic helicates [Ln₂( L ^G )₃]⁶⁺. ¹H‐NMR Data point to the helicates being the only species formed under stoichiometric conditions and having a time‐averaged D₃ symmetry on the NMR time scale. The photophysical properties of L ^G and its helicates are discussed with respect to the closely related ligands L ^B , L ^E , and their complexes, two ligands devoid of the isothiocyanatophenylethynyl substituent. The quantum yield of the ligand fluorescence is three times smaller compared to L ^E , while that of the Eu^III‐centered luminescence (1.1%) is three times larger. On the other hand, the luminescence of Tb^III is not sensitized by L ^G . This is explained in terms of energy differences between the singlet and triplet states on one hand, and between the 0‐phonon transition of the triplet state and the excited metal ion states on the other. This work demonstrates that bulky substituents in the 4‐position of the pyridine ring do not prevent the formation of triple‐stranded helicates, opening the way for luminescent probes that can easily be coupled to biological materials.     

Determination of the relative ligand‐binding strengths in heteroleptic IrIII complexes by ESI‐Q‐TOF tandem mass spectrometry

An electrospray ionization quadrupole time‐of‐flight mass spectrometer has been utilized to investigate the relative ligand‐binding strengths in a series of heteroleptic‐charged iridium(III) complexes of the general formula [(C^N)₂Ir^III(S‐tpy)](PF₆) by using variable collision energies. Collision‐induced dissociation experiments were performed in order to study the stability of the Ir^III complexes that are, for instance, suitable phosphors in light‐emitting electrochemical cells. The ratio of signal intensities belonging to the fragment and the undissociated complex depends on the collision energy applied for the tandem mass spectra (MS/MS) analysis. By defining the threshold collision energy and the point of complete complex dissociation, it is possible to estimate the relative complex stabilities depending on the nature of the coordinated ligands [i.e. type of cyclometalating ligand (C^N), substituents on the S‐shaped terpyridine (S‐tpy)]. The collision energy values differed as a function of the coordination sphere of the Ir^III centers. Copyright © 2011 John Wiley & Sons, Ltd.     

The correct assignment of stereochemistry in di‐μ‐dichlorido‐bis{bis[2‐(5‐benzylsulfonyl)‐3‐fluoro‐2‐(pyridin‐2‐yl)phenyl‐κ2N,C1]iridium(III)} toluene monosolvate

The title complex, [Ir₂(C₁₈H₁₃FNO₂S)₄Cl₂]·C₇H₈, was crystallized from dichloromethane solution under a toluene atmosphere. It is a dimeric complex in which each of the two Ir^III centres is octahedrally coordinated by two bridging chloride ligands and by two chelating cyclometalated 2‐(4‐benzylsulfonyl‐2‐fluorophenyl)pyridine ligands. The crystal structure analysis unequivocally establishes the trans disposition of the two cyclometalated ligands bound to each Ir^III centre, contrary to our previous hypothesis of a cis disposition. The latter was based on the ¹H NMR spectra of a series of dimeric benzylsulfonyl‐functionalized dichloride‐bridged iridium complexes, including the compound described in the present work [Ragni et al. (2009). Chem. Eur. J. 15 , 136–148]. The toluene solvent molecules, embedded in cavities in the crystal structure, are highly disordered and could not be modelled successfully; their contribution was removed from the refinement using the SQUEEZE routine in the program PLATON [Spek (2009). Acta Cryst. D 65 , 148–155].     

Reactions of Pyridyl‐Functionalized,Chelating λ3‐Phosphinines in the Coordination Environment of RhIII and IrIII

Rh^III and Ir^III complexes based on the λ³‐P,N hybrid ligand 2‐(2′‐pyridyl)‐4,6‐diphenylphosphinine ( 1 ) react selectively at the P?C double bond to chiral coordination compounds of the type [( 1 H ? OH)Cp*MCl]Cl ( 2 , 3 ), which can be deprotonated with triethylamine to eliminate HCl. By using different bases, the pK_a value of the P? OH group could be estimated. Whereas [( 1 H ? O)Cp*IrCl] ( 4 ) is formed quantitatively upon treatment with NEt₃, the corresponding rhodium compound [( 1 H ? O)Cp*RhCl] ( 5 ) undergoes tautomerization upon formation of the λ⁵σ⁴‐phosphinine rhodium(III) complex [( 1? OH)Cp*RhCl] ( 6 ) as confirmed by single‐crystal X‐ray diffraction. Blocking the acidic P? OH functionality in 3 by introducing a P? OCH₃ substituent leads directly to the λ⁵σ⁴‐phosphinine iridium(III) complex ( 8 ) upon elimination of HCl. These new transformations in the coordination environment of Rh^III and Ir^III provide an easy and general access to new transition‐metal complexes containing λ⁵σ⁴‐phosphinine ligands.     

Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated IrIII Complex Conjugated to a Far‐Red Emitting Coumarin

Although cyclometalated Ir^III complexes have emerged as promising photosensitizers for photodynamic therapy, some key drawbacks still hamper clinical translation, such as operability in the phototherapeutic window and reactive oxygen species (ROS) production efficiency and selectivity. In this work, a cyclometalated Ir^III complex conjugated to a far‐red‐emitting coumarin, Ir^III–COUPY, is reported with highly favourable properties for cancer phototherapy. Ir^III–COUPY was efficiently taken up by HeLa cells and showed no dark cytotoxicity and impressive photocytotoxicity indexes after irradiation with green and blue light, even under hypoxia. Importantly, a clear correlation between cell death and intracellular generation of superoxide anion radicals after visible light irradiation was demonstrated. This strategy opens the door to novel fluorescent photodynamic therapy agents with promising applications in theragnosis.     

Triphenylamine‐Appended Half‐Sandwich Iridium(III) Complexes and Their Biological Applications

Organometallic half‐sandwich Ir^III complexes of the type [(η⁵‐Cp^x)Ir(N^N)Cl]PF₆ (Cp^x: Cp* or its phenyl Cp^xph or biphenyl Cp^xbiph derivatives; N^N: triphenylamine (TPA)‐substituted bipyridyl ligand groups) were synthesized and characterized. The complexes showed excellent bovine serum albumin (BSA) and DNA binding properties and were able to oxidize NADH to NAD⁺ (NAD=nicotinamide adenine dinucleotide) efficiently. The complexes induced apoptosis effectively and led to the emergence of reactive oxygen species (ROS) in cells. All complexes showed potent cytotoxicity with IC₅₀ values ranging from 1.5 to 7.1 μm toward A549 human lung cancer cells after 24 hours of drug exposure, which is up to 14 times more potent than cisplatin under the same conditions.     

Group 9 Metal Complexes of meso‐Aryl‐Substituted Rubyrin

The metalation of meso‐tetrakis(pentafluorophenyl)‐substituted [26]rubyrin has been explored with Group 9 metal salts (Rh^I, Co^II, Ir^III), affording a Hückel aromatic [26]rubyrin–bis‐Rh^I complex with a highly curved gable‐like structure, a Hückel antiaromatic [24]rubyrin–bis‐Co^II complex that displays intramolecular antiferromagnetic coupling between the two Co^II ions (J=?4.5 cm^?1), and two Cp*‐capped Ir^III complexes; in one, the iridium metal sits on the [26]rubyrin frame with two Ir?N bonds, whereas the other has an additional Ir?C bond, although both Ir^III complexes display moderate aromatic character. This work demonstrates characteristic metalation abilities of this [26]rubyrin toward Group 9 metals.     

Iridium(III) Complexes Bearing Pyrene‐Functionalized 1,10‐Phenanthroline Ligands as Highly Efficient Sensitizers for Triplet–Triplet Annihilation Upconversion

“Chemistry‐on‐the‐complex” synthetic methods have allowed the selective addition of 1‐ethynylpyrene appendages to the 3‐, 5‐, 3,8‐ and 5,6‐positions of Ir^III‐coordinated 1,10‐phenanthroline via Sonogashira cross‐coupling. The resulting suite of complexes has given rise to the first rationalization of their absorption and emission properties as a function of the number and position of the pyrene moieties. Strong absorption in the visible region (e.g. 3,8‐substituted Ir‐3 : λ_abs=481 nm, ?=52 400 m ^?1 cm^?1) and long‐lived triplet excited states (e.g. 5‐substituted Ir‐2 : τ_T=367.7 μs) were observed for the complexes in deaerated CH₂Cl₂. On testing the series as triplet sensitizers for triplet–triplet annihilation upconversion, those Ir^III complexes bearing pyrenyl appendages at the 3‐ and 3,8‐positions ( Ir‐1 , Ir‐3 ) were found to give optimal upconversion quantum yields (30.2 % and 31.6 % respectively).     

Luminescent Bimetallic Lanthanide Bioprobes for Cellular Imaging with Excitation in the Visible‐Light Range

A series of homoditopic ligands H₂L^CX (X=4–6) has been designed to self‐assemble with lanthanide ions (Ln^III), resulting in neutral bimetallic helicates of overall composition [Ln₂(L^CX)₃] with the aim of testing the influence of substituents on the photophysical properties, particularly the excitation wavelength. The complex species are thermodynamically stable in water (log β₂₃ in the range 26–28 at pH 7.4) and display a metal‐ion environment with pseudo‐D₃ symmetry and devoid of coordinated water molecules. The emission of Eu^III, Tb^III, and Yb^III is sensitised to various extents, depending on the properties of the ligand donor levels. The best helicate is [Eu₂(L^C5)₃] with excitation maxima at 350 and 365 nm and a quantum yield of 9 %. The viability of cervix cancer HeLa cells is unaffected when incubated with up to 500 μm of the chelate during 24 h. The helicate permeates into the cells by endocytosis and locates into lysosomes, which co‐localise with the endoplasmatic reticulum, as demonstrated by counterstaining experiments. The relatively long excitation wavelength allows easy recording of bright luminescent images on a confocal microscope (λ_exc=405 nm). The new lanthanide bioprobe remains undissociated in the cell medium, and is amenable to facile derivatisation. Examination of data for seven Eu^III and Tb^III bimetallic helicates point to shortcomings in the phenomenological rules of thumb between the energy gap ΔE(³ππ*–⁵D_J) and the sensitisation efficiency of the ligands.     

Iron(II) Supramolecular Helicates Condense Plasmid DNA and Inhibit Vital DNA‐Related Enzymatic Activities

The dinuclear iron(II) supramolecular helicates [Fe₂L₃]Cl₄ (L=C₂₅H₂₀N₄) bind to DNA through noncovalent (i.e., hydrogen‐bonding, electrostatic) interactions and exhibit antimicrobial and anticancer effects. In this study, we show that the helicates condense plasmid DNA with a much higher potency than conventional DNA‐condensing agents. Notably, molecules of DNA in the presence of the M enantiomer of [Fe₂L₃]Cl₄ do not form intermolecular aggregates typically formed by other condensing agents, such as spermidine or spermine. The helicates inhibit the activity of several DNA‐processing enzymes, such as RNA polymerase, DNA topoisomerase I, deoxyribonuclease I, and site‐specific restriction endonucleases. However, the results also indicate that the DNA condensation induced by the helicates does not play a crucial role in these inhibition reactions. The mechanisms for the inhibitory effects of [Fe₂L₃]Cl₄ helicates on DNA‐related enzymatic activities have been proposed.     

Cation‐Controlled Formation and Interconversion of the fac/fac and mer/mer Stereoisomers of a Triple‐Stranded Helicate

Two biscatecholester ligands with oligoether spacers were used to prepare dinuclear titanium(IV) triscatecholate based helicates. In the case of Li₄[( 1 / 2 )₃Ti₂], “classical” helicates with three internally bound Li⁺ ions and syn‐oriented ligands in the complex units (fac/fac isomer) were obtained. In the case of the sodium salt Na₄[( 2 )₃Ti₂], a different homochiral dinuclear triple‐stranded helicate with two internally bound Na⁺ ions was formed. The complex units are anti‐configured, and two of the ligand spacers are connecting internal with external positions of the helicate (mer/mer isomer). Removal of the sodium ions and addition of lithium ions leads to the switching from one topology to the other with an expanded helicate [( 2 )₃Ti₂]^4? as an intermediate. Switching back to the “non‐classical” helicate cannot be observed because severe structural rearrangements would be required.     

Synthesis and photophysical properties of Ir<Superscript>III</Superscript>-Ln<Superscript>III</Superscript> (Ln = Nd,Yb, Er) bimetallic complexes containing bipyrimidines as bridging ligands

Bipyrimidines have been chosen as (N∧N)(N∧N) bridging ligands for connecting metal centers. Ir^III-Ln^III (Ln = Nd, Yb, Er) bimetallic complexes [Ir(dfppy)₂(μ-bpm)Ln(TTA)₃]Cl were synthesized by using Ir(dfppy)₂(bpm)Cl as the ligand coordinating to lanthanide complexes Ln(TTA)₃·2H₂O. The stability constants between Ir(dfppy)₂(bpm)Cl and lanthanide ions were measured by fluorescence titration. The obvious quenching of visible emission from Ir^III complex in the Ir^III-Ln^III (Ln = Nd, Yb, Er) bimetallic complexes indicates that energy transfer occurred from Ir^III center to lanthanides. NIR emissions from Nd^III, Yb^III, and Er^III were obtained under the excitation of visible light by selective excitation of the Ir^III-based chromophore. It was proven that Ir(dfppy)₂(bpm)Cl as the ligand could effectively sensitize NIR emission from Nd^III, Yb^III, and Er^III.